Benefits

Retrospective 2022 Drug data trends and national benchmarks

Issue link: http://read.uberflip.com/i/1498117

Contents of this Issue

Navigation

Page 0 of 57

TELUS Proprietary 1 Retrospective 2022: Drug trends and national benchmarks April 26, 2023 Daniel Drolet Industry Expert and Senior Partner, Group Benefits Normandin Beaudry

Articles in this issue

view archives of Benefits - Retrospective 2022 Drug data trends and national benchmarks